These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 366579)

  • 21. [Clinical trial with a nonamphetaminic anoretic].
    Campagnoli M
    Rev Iber Endocrinol; 1976; 23(137):463-83. PubMed ID: 794978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of obesity with a non-amphetamine anorexigenic agent (author's transl)].
    Riesco J; Troncoso G; Costamaillere L; Rodríguez J
    Rev Med Chil; 1977 Jun; 105(6):375-9. PubMed ID: 331428
    [No Abstract]   [Full Text] [Related]  

  • 23. [Mazindol (AN 448 Sandoz) in ambulatory treatment of obesity; its effect on body composition and adipose tissue].
    Rath R; Vondra K; Wenkeová J
    Cesk Gastroenterol Vyz; 1977 Sep; 31(6):389-94. PubMed ID: 589677
    [No Abstract]   [Full Text] [Related]  

  • 24. [Mazindol: a new anorectic drug].
    Siani V
    Clin Ter; 1978 Jan; 84(1):100-1. PubMed ID: 630811
    [No Abstract]   [Full Text] [Related]  

  • 25. Mazindol.
    Med Lett Drugs Ther; 1982 Oct; 24(621):98. PubMed ID: 7144688
    [No Abstract]   [Full Text] [Related]  

  • 26. Slowed gastric evacuation accounts for the reduction of food intake by anorectic drugs.
    Jonderko K; Kucio C; Skrzypek D
    Eur J Clin Nutr; 1988 Jul; 42(7):627-31. PubMed ID: 3066620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of the effect of mazindol on the motor function of the stomach in obese persons].
    Kucio C; Jonderko K; Skrzypek D
    Pol Arch Med Wewn; 1988 Apr; 79(4):195-9. PubMed ID: 3270813
    [No Abstract]   [Full Text] [Related]  

  • 28. Double-blind clinical evaluation of mazindol (42-548) in obese diabetics.
    Bandisode MS; Boshell BR
    Curr Ther Res Clin Exp; 1975 Dec; 18(6):816-24. PubMed ID: 813947
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of mazindol (teronac) on various hormonal indicators in children with simple obesity].
    Komorowski JM; Zwaigzne-Raczyńska J; Owczarczyk I; Gołebiowska M; Zarzycki J
    Pediatr Pol; 1982 Apr; 57(4):241-6. PubMed ID: 6755371
    [No Abstract]   [Full Text] [Related]  

  • 30. Mazindol (Teronac)- another anorectic drug.
    Drug Ther Bull; 1974 Dec; 12(26):101-2. PubMed ID: 4459058
    [No Abstract]   [Full Text] [Related]  

  • 31. [Evaluation of the effect of mazindol on the metabolism and lipolysis in obese women].
    Kucio C; Zahorska-Markiewicz B; Piskorska D; Semenowicz-Siuda K; Waluga M
    Pol Arch Med Wewn; 1987 Mar; 77(3):73-6. PubMed ID: 3275392
    [No Abstract]   [Full Text] [Related]  

  • 32. A multicentre study comparing mazindol and placebo in obese patients.
    Walker BR; Ballard IM; Gold JA
    J Int Med Res; 1977; 5(2):85-90. PubMed ID: 326596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The clinical evaluation of teronac (Mazindol) in the treatment of children with obesity. Part I. Effect of the drug on somatic patterns and exercise capacity (author's transl)].
    Gołebiowska M; Chlebna-Sokoł D; Mastalska A; Zwaigzne-Raczyńska J
    Przegl Lek; 1981; 38(2):311-4. PubMed ID: 7017826
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of obesity using a new anorectic].
    Felt V
    Vnitr Lek; 1976 Apr; 22(4):371-4. PubMed ID: 1266099
    [No Abstract]   [Full Text] [Related]  

  • 35. [Mazindol in the treatment of obesity in diabetics (author's transl)].
    Felt V; Nedvídková J
    Cas Lek Cesk; 1977 Sep; 116(39):1214-7. PubMed ID: 922789
    [No Abstract]   [Full Text] [Related]  

  • 36. [Drug therapy in obesity].
    Ishii J
    Nihon Rinsho; 1988 Nov; 46(11):2491-6. PubMed ID: 3241376
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of teronak for the treatment of obesity with and without diabetes mellitus].
    Egart FM; Korotkova VD
    Probl Endokrinol (Mosk); 1980; 26(2):16-20. PubMed ID: 7375451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Letter: Drugs in obesity.
    Jackson WP; Vinik AI
    S Afr Med J; 1975 May; 49(20):803. PubMed ID: 1098170
    [No Abstract]   [Full Text] [Related]  

  • 39. [Long-term treatment of patients with obesity using mazindol and a reducing diet].
    van Seters AP; Bouwhuis-Hoogerwerf ML; Goslings BM; van Nieuwkoop L; van Slooten H; Struijk-Wielinga T
    Ned Tijdschr Geneeskd; 1982 May; 126(22):990-4. PubMed ID: 7110390
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of obesity: comparison of physician and nonphysician therapists using placebo and anorectic drugs in a double-blind trial.
    Atkinson RL; Greenway FL; Bray GA; Dahms WT; Molitch ME; Hamilton K; Rodin J
    Int J Obes; 1977; 1(2):113-20. PubMed ID: 363629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.